Timeline and outcomes of viral and fungal infections after chimeric antigen receptor T-cell therapy: a large database analysis

This publication has 34 references indexed in Scilit:

• A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
  Nature Medicine, 2024
• Human Herpes Virus 6 Dnaemia within 1 Year of Chimeric Antigen Receptor T Cell Therapy
  Transplantation and Cellular Therapy, 2023
• Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians
  Expert Review of Hematology, 2022
• Herpesviruses Infections in CAR T Cell Recipients
  Transplantation and Cellular Therapy, 2022
• State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses
  Transplantation and Cellular Therapy, 2021
• Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?
  The Lancet Haematology, 2021
• Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
  Blood Cancer Journal, 2020
• Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells
  Transplantation and Cellular Therapy, 2020
• Chimeric Antigen Receptor Therapy
  New England Journal of Medicine, 2018
• Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
  Nature Reviews Clinical Oncology, 2017